vs

Side-by-side financial comparison of Performance Shipping Inc. (PSHG) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $39.5M, roughly 1.1× Performance Shipping Inc.). Performance Shipping Inc. runs the higher net margin — 97.5% vs -17.2%, a 114.8% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -7.9%).

Azerbaijan Caspian Shipping Closed Joint-Stock Company is a state-owned Azerbaijani shipping company. It is also known by its Russian-derived abbreviation CASPAR.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

PSHG vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.1× larger
STIM
$41.8M
$39.5M
PSHG
Growing faster (revenue YoY)
STIM
STIM
+93.7% gap
STIM
85.7%
-7.9%
PSHG
Higher net margin
PSHG
PSHG
114.8% more per $
PSHG
97.5%
-17.2%
STIM

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
PSHG
PSHG
STIM
STIM
Revenue
$39.5M
$41.8M
Net Profit
$38.5M
$-7.2M
Gross Margin
52.0%
Operating Margin
93.3%
-12.1%
Net Margin
97.5%
-17.2%
Revenue YoY
-7.9%
85.7%
Net Profit YoY
78.1%
43.2%
EPS (diluted)
$1.00
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PSHG
PSHG
STIM
STIM
Q4 25
$41.8M
Q3 25
$37.3M
Q2 25
$39.5M
$38.1M
Q1 25
$32.0M
Q4 24
$22.5M
Q3 24
$18.5M
Q2 24
$42.9M
$16.4M
Q1 24
$17.4M
Net Profit
PSHG
PSHG
STIM
STIM
Q4 25
$-7.2M
Q3 25
$-9.0M
Q2 25
$38.5M
$-10.1M
Q1 25
$-12.7M
Q4 24
$-12.7M
Q3 24
$-13.3M
Q2 24
$21.6M
$-9.8M
Q1 24
$-7.9M
Gross Margin
PSHG
PSHG
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
PSHG
PSHG
STIM
STIM
Q4 25
-12.1%
Q3 25
-19.6%
Q2 25
93.3%
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
49.1%
-51.7%
Q1 24
-39.4%
Net Margin
PSHG
PSHG
STIM
STIM
Q4 25
-17.2%
Q3 25
-24.3%
Q2 25
97.5%
-26.6%
Q1 25
-39.6%
Q4 24
-56.4%
Q3 24
-72.0%
Q2 24
50.4%
-59.8%
Q1 24
-45.2%
EPS (diluted)
PSHG
PSHG
STIM
STIM
Q4 25
$-0.10
Q3 25
$-0.13
Q2 25
$1.00
$-0.15
Q1 25
$-0.21
Q4 24
$-0.34
Q3 24
$-0.44
Q2 24
$0.55
$-0.33
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PSHG
PSHG
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$95.8M
$28.1M
Total DebtLower is stronger
$43.7M
$65.8M
Stockholders' EquityBook value
$312.8M
$22.4M
Total Assets
$363.8M
$141.6M
Debt / EquityLower = less leverage
0.14×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PSHG
PSHG
STIM
STIM
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$95.8M
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$61.7M
$42.6M
Q1 24
$47.7M
Total Debt
PSHG
PSHG
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$43.7M
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$51.2M
$59.8M
Q1 24
$59.4M
Stockholders' Equity
PSHG
PSHG
STIM
STIM
Q4 25
$22.4M
Q3 25
$27.4M
Q2 25
$312.8M
$27.1M
Q1 25
$35.5M
Q4 24
$27.7M
Q3 24
$9.4M
Q2 24
$254.0M
$19.4M
Q1 24
$27.7M
Total Assets
PSHG
PSHG
STIM
STIM
Q4 25
$141.6M
Q3 25
$145.5M
Q2 25
$363.8M
$134.7M
Q1 25
$142.0M
Q4 24
$140.9M
Q3 24
Q2 24
$310.5M
$96.8M
Q1 24
$103.8M
Debt / Equity
PSHG
PSHG
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
0.14×
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
0.20×
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PSHG
PSHG
STIM
STIM
Operating Cash FlowLast quarter
$26.8M
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PSHG
PSHG
STIM
STIM
Q4 25
$908.0K
Q3 25
$-785.0K
Q2 25
$26.8M
$-3.5M
Q1 25
$-17.0M
Q4 24
$-8.6M
Q3 24
$-5.4M
Q2 24
$31.7M
$-5.0M
Q1 24
$-12.0M
Free Cash Flow
PSHG
PSHG
STIM
STIM
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
Q1 24
$-12.4M
FCF Margin
PSHG
PSHG
STIM
STIM
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Q1 24
-71.1%
Capex Intensity
PSHG
PSHG
STIM
STIM
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
0.0%
3.7%
Q1 24
2.2%
Cash Conversion
PSHG
PSHG
STIM
STIM
Q4 25
Q3 25
Q2 25
0.70×
Q1 25
Q4 24
Q3 24
Q2 24
1.47×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons